Clinical trial
Influence of Persistent CMV-infection on Immune Senescence
NCT00461695 · University of Zurich, Other · Completed
Key facts
| NCT number | NCT00461695 |
|---|---|
| Title | Influence of Persistent CMV-infection on Immune Senescence |
| Official title | Influence of Persistent CMV-infection on Immune Senescence Evaluated With a Prospective Vaccination Trial Against Tick-borne Encephalitis Virus in Healthy Elderly Individuals (CYTEL-Study) |
| Lead sponsor | University of Zurich, Other |
| Collaborators | Division of Infectious Diseases and Hospital Epidemiology |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Immune Senescence |
| Intervention type | Biological |
| Interventions | Vaccination against TBEV (FSME Immun CC) |
| Enrollment | 183 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | Apr 18, 2007 |
| Last update posted | Aug 27, 2013 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: